Context: Patients with congenital adrenal hyperplasia (CAH) are at risk for life-threatening adrenal crises. Management of illness episodes aims to prevent adrenal crises.
C ongenital adrenal hyperplasia (CAH) is an autosomalrecessive group of disorders characterized by adrenocortical enzyme deficiency, the most common form being 21-hydroxylase deficiency. In its most severe form (classic CAH), patients have cortisol deficiency, and CAH is the most common cause of primary adrenal insufficiency during childhood (1) .
Patients are therefore at risk for life-threatening adrenal crises and excess mortality (1, 2) .
Infant mortality in patients with CAH has decreased since the advent of neonatal screening (3) , but fatal adrenal crises still occur. Since the introduction of glucocorticoid therapy in the 1950s, patients with classic CAH survive into adulthood, thus long-term outcomes are of the utmost importance (4) . New and improved ways of replacing cortisol are being studied in an attempt to reduce comorbidities and improve long-term outcomes (5, 6) , but studies aimed at evaluating and changing stress-related glucocorticoid treatment are lacking.
CAH has been associated with excess mortality, with adrenal crisis reported as the leading cause of death in a cohort of 588 patients with CAH from the Swedish national registry (2) , ahead of cardiovascular disease, which is the leading cause of death in adults globally (7) . Similarly, increased mortality in Addison disease has been attributed to adrenal crisis (8) . Prevention of adrenal crises in patients with known adrenal insufficiency is key and is thought to be best accomplished through structured and repeated patient education regarding stressrelated glucocorticoid dosing (9, 10) .
In this study, we sought to characterize the rates and causes of glucocorticoid stress dosing and related consequences [emergency room (ER) visits, hospitalizations, and adrenal crises] in our large cohort of patients with CAH followed prospectively at the National Institutes of Health (NIH) Clinical Center who receive patient education regarding glucocorticoid stress dosing at each visit. We investigated the association of these outcomes with phenotype, age, daily medication doses, and hormonal evaluations.
Patients and Methods

Patients
The records of 156 patients enrolled in the CAH Natural History Study at the NIH Clinical Center (Bethesda, MD; www. clinicaltrials.gov identifier NCT00250159) were reviewed (11) . Diagnoses were confirmed by hormonal testing and genotyping (12) . Criteria for inclusion were treatment with glucocorticoids, and age younger than 5 years, or ongoing clinical care of at least 3 years' duration at the NIH. Patients with CAH due to any type of enzyme deficiency were included. Phenotype classification [salt-wasting (SW), simple virilizing (SV), and nonclassic (NC)] was based on clinical and hormonal criteria as previously described (11) . The study was approved by the Eunice Kennedy Shriver National Institute of Child Health and Development Institutional Review Board and all patients (adults) or parents (children) provided written informed consent. Children at least 8 years old provided written assent.
Children were seen on average every 6 months, with laboratory evaluations every 3 months, and adults were seen annually. All patients underwent a standard history and physical examination, biochemical testing, and genetic testing to confirm the diagnosis of CAH. At each visit, an endocrinologist performed a physical examination and took a patient history. Data were gathered about illnesses, surgical procedures, and stress dosing since the previous visit. Patients were routinely asked about ER visits and hospitalizations in the interim period. Adrenal crisis was defined as a hospitalization or ER admission requiring administration of intravenous fluid and glucocorticoid, with resolution of symptoms following this therapy. This information was systematically compiled, and illnesses were divided into subcategories based on patient (parent) description. Teaching by a nurse regarding stress-related glucocorticoid dosing occurred with each visit (1, 13). Written instructions were provided and included: hydrocortisone doses doubled (children: fever .38°C; adults: minor febrile illness) or tripled (children: .39°C; adults: major febrile illness) until recovery and for gastrointestinal illness regardless of fever, intramuscular injection of hydrocortisone for vomiting and increased fluid and glucose intake. Our preference is to use hydrocortisone for stress dosing; therefore, adult patients receiving long-acting glucocorticoids were instructed to take hydrocortisone 10 to 20 mg three times a day in addition to their usual glucocorticoid regimen. All adult patients and parents were taught one-on-one how to administer or self-administer (patients) an intramuscular injection of hydrocortisone. Repeat-injection teaching was provided at each visit.
Assays
Assessment at each visit included early morning (approximately 0800 hours) measurement of 17-hydroxyprogesterone (17-OHP), androstenedione, and plasma renin activity prior to medication. Approximately every 1 to 2 years, patients underwent additional biochemical testing, including measurement of cortisol, adrenocorticotropic hormone, and resting epinephrine following 30 minutes lying supine. Additional testing was performed if clinically indicated.
Hormones were analyzed at the NIH Clinical Center (Bethesda, MD), unless noted otherwise. Androstenedione and 17-OHP were measured by liquid chromatographytandem mass spectrometry (Mayo Medical Laboratories until 2012 and NIH after 2012). Plasma renin activity was measured by radioimmunoassay (Mayo Medical Laboratories, Rochester, MN). Cortisol and adrenocorticotropic hormone were measured by chemiluminescent immunometric assay; plasma epinephrine was measured by high-performance liquid chromatography.
Clinical and laboratory data definitions
For phenotype analysis, three patients with 11b-hydroxylase deficiency were included with the SV group, and one patient with classic 3b-hydroxysteroid dehydrogenase deficiency was included with the SW group. Body mass index (BMI) percentile was calculated for children using U.S. anthropometric reference data (14) . Hydrocortisone equivalency dose was calculated by multiplying prednisone dose by 5 or dexamethasone dose by 80 (11) . Illnesses were grouped by system and etiology, with "other" illnesses mostly including unspecified etiology or random causes not otherwise categorizable, such as tattoo or sunburn (Fig. 1) . 17-OHP was stratified as #1200 vs .1200 ng/dL. Epinephrine was dichotomized as detectable or undetectable.
Statistics
This was a longitudinal analysis of repeated measures (multiple visits) from patients with CAH over 23 years. Analyses were carried out at the visit level as independent observations. The data were divided into pediatric (age ,18 years) and adult visits and stratified by classic and NC patients. Main outcome measures were rates of illnesses and stress-dose days and occurrences of ER visits, hospitalizations, and adrenal crises between consecutive visits. Laboratory and clinical data obtained at each visit were used to assess their associations with outcomes since the last visit; the midpoint age between two consecutive visits was used as the age variable. Rates of illnesses and stress-dose days were computed using the number of events divided by the time between visits (in years); incidence of adrenal crises was determined based on person-time years. Comparisons between groups were carried out using generalized linear models through nonlinear Poisson and binomial functions and log or logit link functions and accounted for the number of visits each patient contributed. The model was fit by generalized estimating equations, which accounted for the correlated data from repeat observations. Statistical significance was based on magnitude of effect using odds ratios (ORs), 95% confidence intervals (CIs), and P values ,0.05. Results are reported as frequencies and percentages, mean 6 standard deviation, or OR (95% CI). Data were analyzed using SAS v9.4 (SAS Institute, Inc, Cary, NC).
Results
The cohort consisted of 156 patients (42% females) and 2298 visits (1909 for children and 389 for adults) with an average of 16.9 6 11.5 visits/patient for children and 5.1 6 2.7 visits/patient for adults. Patients were followed for an average of 9.3 6 6.0 years, with the longest duration of 23.4 years. The age at first appointment ranged from 1.5 months to 63 years (mean 11.1 6 13.0 years), and age at last appointment ranged from 8.4 months to 68 years (mean 20.4 6 13 years). The average number of observations (visits) per patient was 14.7 6 11.4. The cohort consisted of 81% pediatric and 19% adult patients at the first visit and 51% pediatric and 49% adult patients at the last visit. The majority (97.4%) of patients had 21-hydroxylase deficiency (62.2% SW, 26.9% SV, and 8.3% NC), and 2.6% of patients had other rare types of CAH.
Among classic patients, greater rates of illnesses and stress dosing occurred during childhood than adulthood [OR 3.27 (95% CI 1.74 to 6.15), P = 0.002; and OR 4.99 (95% CI 3.35 to 7.42), P , 0.0001, respectively]; however, the probability of ER visits and hospitalizations was higher during adulthood [OR 1.50 (95% CI 1.04 to 2.17), P = 0.03; and OR 1.94 (95% CI 1.13 to 3.32), P = 0.02, respectively]. Adrenal crises occurred with an incidence of 7.55 out of 100 patient-years; rates were lower in children than adults (7.2 out of 100 vs 10.2 out of 100 patient-years); however, the difference was not statistically noteworthy.
During childhood for patients with classic CAH, younger age (P , 0.0001 and P , 0.0001), female sex (P = 0.01 and P = 0.02), lower hydrocortisone dose (P , 0.001 and P = 0.01), and higher fludrocortisone dose (P = 0.02 and P = 0.02) were associated with higher rates of total illnesses and days stress dosed, respectively, and lower BMI percentile was associated with higher rates of illnesses (P = 0.02), even when adjusted for hydrocortisone dose (Table 1) . Patients with SW had more ER visits than patients with SV during childhood (P = 0.01); phenotype differences were not found during adulthood. Children with undetectable epinephrine were more likely to have an ER visit than those with detectable epinephrine (P = 0.03). Undetectable epinephrine was associated with higher rates of illness episodes during adulthood (P = 0.03) ( Table 2 ). Elevated plasma renin activity was associated with increased number of ER visits (P = 0.02) and adrenal crises during childhood (P = 0.04).
During adulthood for patients with classic CAH, females had more stress-dose days than males (P = 0.02) ( Table 2 ). In both children and adults, there was no association between 17-OHP levels and any of the outcomes. Unlike childhood, lower fludrocortisone doses were associated with more hospitalizations during adulthood (P = 0.04). Clinical and hormonal data were not associated with adrenal crises during adulthood.
Multivariable models for each of the outcomes were performed for patients with classic CAH if variables were robust at the univariate level. For rates of total illness and days stress dosed, younger age, lower hydrocortisone equivalency dose (total illness only), and higher fludrocortisone dose remained the most robust predictors during childhood (data not shown), whereas female sex was the only notable predictor for days of stress dosing during adulthood. Lower fludrocortisone doses during adulthood was a predictor of higher ER visits and hospitalizations during adulthood.
For NC CAH, only two patients had ER visits and/or hospitalizations: one 11-year-old was hospitalized for adrenal crisis with a gastrointestinal illness while receiving 14.8 mg/kg/m 2 of hydrocortisone; and one 18-yearold had an ER visit with subsequent hospitalization for nephrolithiasis. NC girls had more stress-dose days than NC boys [OR 22 .08 (95% CI 5.15 to 94.6); P , 0.001]. In NC adults, higher BMI was associated with higher rate of illness [OR 1.27 (95% CI 1.02 to 1.59); P = 0.03].
Upper respiratory tract illness, followed by gastrointestinal illness, were the main causes of stress dosing and adrenal crises across all ages ( Figs. 1 and 2 ). As expected, the most common reason for stress dosing was a self-limited community-acquired illness, whereas injury and surgery accounted for 10% of stress dosing in children and 17% of stress dosing in adults. Ten percent of stress-dosing episodes during childhood and 27% percent of stress-dosing episodes during adulthood were for mental stress and other reasons contrary to our glucocorticoid stress-dose teaching (Fig. 2) . The main precipitating factors for hospitalization in children were gastrointestinal followed by URIs, whereas in adults, causes for hospitalizations varied with no predominant precipitating factor and included viral meningitis, dehydration, intestinal obstruction, and inguinal hernia.
Adrenal crisis with probable hypoglycemia occurred in 11 patients (five males and six females) between the ages of 1.1 and 11.3 years, with varied precipitating infectious causes (Table 3 ). In two-thirds of the cases, stress doses of hydrocortisone had been given according to glucocorticoid stress-dose instructions for 1 to 4 days prior to the hypoglycemic episode. Most notable is patient 8, who had a norovirus-associated gastrointestinal illness while traveling, became unresponsive, and had a seizure with subsequent encephalopathy and probable permanent consequences.
Discussion
We report in this study a comprehensive evaluation of illness episodes, glucocorticoid stress-dosing habits, and associated outcomes of a large cohort of patients with glucocorticoid-treated CAH followed over a period of up to 23 years at the NIH. Intensive, frequent, and repeated glucocorticoid stress-dose teaching allowed patients to often be successfully managed at home during illness episodes; however, adrenal crises requiring hospitalizations and hypoglycemia still occurred. Children had higher rates of illnesses and stress dosing than adults, whereas adults had more ER visits, hospitalizations, and adrenal crises and were also more likely to stress dose for reasons contrary to our guidelines. Among children with classic CAH, the most robust predictors of glucocorticoid stress dosing and illnesses were young age and replacement doses (low glucocorticoid and high mineralocorticoid). Although the majority of patients stress dosed appropriately with illnesses, hypoglycemia occurred in 11 pediatric patients, with one patient having encephalopathy and probable long-term sequela. Epinephrine deficiency may play a role in the development of adrenal crisis, as having undetectable epinephrine levels at routine clinic visits was a risk factor for needing an ER visit (childhood) and increased illness episodes (adulthood). Pediatricians aim to minimize glucocorticoid dose during childhood to optimize growth and avoid iatrogenic Cushing syndrome (4). Our data suggest that this may be at the expense of an increased risk of illness episodes with possible adrenal crisis because children receiving lower hydrocortisone doses had higher rates of stress dosing and illnesses. The opposite was seen with fludrocortisone: higher doses had higher rates; this has been previously reported (15) , and is likely explained by higher fludrocortisone dose reflecting considerable SW. In adults, the opposite was observed: lower fludrocortisone doses were associated with higher hospitalization rates, possibly due to the tendency to lower fludrocortisone in adults, which might increase SW with illnesses. Typical biomarkers of hormonal control were not robust predictors of rates of illness and associated events, similar to a study by Yang and White (15) . Our study evaluates illness episodes in relation to epinephrine, which may play a role in susceptibility to adrenal crisis.
We found that females had more illnesses (children) and days of stress dosing (all ages and all types CAH) than males. We postulate that for young classic girls, this could bear a relation to the presence of atypical genitalia at birth with subsequent surgery in the majority of patients. Similarly, a sex difference in hospitalization rates in young patients with CAH was reported in Australia, with females hospitalized more often than males (16) . It is possible that greater parental stress results in overzealous stress dosing of females at young ages. The increase in stress dosing of older females might reflect sex differences in health behavior.
Subclinical impairment of cortisol secretion occurs in approximately one-third of NC patients with CAH not receiving glucocorticoid therapy (17, 18) , and, to our knowledge, adrenal crisis has not been reported in these patients. The Endocrine Society clinical practice guidelines for the management of CAH (4) and primary adrenal insufficiency (1) suggest judicious use of glucocorticoid in NC patients, and even mild cortisol impairment generally does not lead to Addisonian crisis (1, 17, 18) . However, in NC patients receiving glucocorticoid therapy, adrenal crisis is possible, albeit rare, and secondary to iatrogenic hypothalamic-pituitary-adrenal axis suppression. In our cohort, one NC patient was hospitalized for adrenal crisis associated with a gastrointestinal illness while receiving glucocorticoid therapy.
Gastrointestinal and upper respiratory illness were the leading causes for stress dosing, hospitalization, and adrenal crises across all ages, with gastrointestinal illness being the predominant precipitant for hospitalization in children. As expected, we found that SW children had more ER visits than SV or NC children, consistent with previous findings (19) . However, during adulthood, differences according to phenotype were not observed, supporting the notion that clinical status in adults is mostly related to long-term disease control rather than genotype/phenotype (20, 21) . Our finding of increased stress dosing and illness episodes in children but increased number of ER visits and hospitalizations in adults suggests that adults may be more vigilant in monitoring their children's signs and symptoms of adrenal crisis (and preventing hospitalizations) than they are at monitoring and treating themselves. In an Australian cohort of adults with CAH, older adults had the highest hospital admission rates, with infections accounting for the majority of admissions (22) . Our patients older than 40 years of age had varied reasons for hospitalizations including noninfectious causes, such as dehydration and intestinal obstruction.
Prior studies report an incidence of adrenal crises in adults with adrenal insufficiency between 4.9 and 8.3 per 100 patient-years (19, (23) (24) (25) and in children 6.5 per 100 patient-years (26) . Data from a United States-based large national database showed that patients with adrenal insufficiency are at increased risk of hospitalizations and comorbities (27) , and between 8% and 12% of adults and children with adrenal insufficiency are expected to require hospitalization because of adrenal crisis annually (16, 28) . All of the patients in our study were followed at our center prospectively for at least 3 years and therefore received stress-dose teaching multiple times, including self-administration (lay) of parenteral hydrocortisone, and all patients had a home supply of injectable hydrocortisone. Adrenal crises occurred with an incidence of 7.55 per 100 patient-years, comparable to that reported in other populations, implying that current recommended teaching requires improvement, or adrenal crises may not always be preventable. However, adrenal crisis rates were somewhat lower in children than adults (7.2 vs 10.2 per 100 patient-years) despite children having significantly higher rates of illness, suggesting that successful home management of illnesses was commonly achieved during childhood.
Adrenal crisis occurs when circulating levels of adrenal steroids are insufficient for physiological requirements. There is no standardized definition of adrenal crisis, but hypotension is considered a cardinal feature, and acute deterioration in health requiring parenteral glucocorticoid administration is present (29) . Two risk factors have been consistently associated with risk of adrenal crisis in CAH: young age and precipitating gastrointestinal illness (15, 19, 24, 30 ). In a cross-sectional study of 122 adults with CAH (19), gastrointestinal illness was the leading cause of adrenal crisis (29%), with most occurring in the first decade of life. Although we found that gastrointestinal illness was a leading cause of glucocorticoid stress dosing and adrenal crises across all ages, it was only associated with one-third of hypoglycemic episodes. Multiple studies have consistently found younger age to be a risk factor for crisis. Furthermore, one study revealed for children with CAH younger than age 5, parents' perceived ability to manage adrenal crises was low when compared with parents of older children (31) . Combining vulnerability, younger age, and not-yet-experienced parents further places this group of children at risk and warrants tighter guidelines for adrenal crisis management.
A crucial consequence of adrenal crises is hypoglycemia, and complications include seizures and possible neurologic sequela. We report in this study a 4.5-year-old patient who developed a prolonged seizure with subsequent coma several hours after the onset of a gastrointestinal illness (subsequently diagnosed with norovirus) (patient 8; Table 3 ). In one retrospective study of patients with primary and secondary adrenal insufficiency who developed severe adrenal crisis, six out of 10 rapidly progressing adrenal crises were associated with hypoglycemia (five of which occurred in children under 5) despite receiving glucocorticoid stress dosing, and the majority of crises occurred without electrolyte abnormalities (32) . Similarly, our patients with hypoglycemia did not experience electrolyte abnormalities, and overall, adverse outcomes appeared to be related more to hypoglycemia than electrolyte disturbances. In a study of 102 Bavarian children with classic CAH, 16 hypoglycemic episodes occurred without salt loss, and 11 cases of hypoglycemia occurred unexpectedly, mostly in the early morning (26) . In a retrospective study of patients with CAH with encephalopathy, 14 out of 15 patients had seizures, including some with refractory seizures and coma (33) . Ten (71.4%) of the 14 patients with seizures had low (,70 mg/dL) glucose, including four with undetectable levels. Less severe neurologic consequences, including learning difficulties in patients with CAH, has also been reported in relation to hypoglycemia (34). In our most severe illness cases, patients with hypoglycemia, 67% had at least 24 hours of decreased oral intake, 50% had symptoms of hypoglycemia in the early morning, 33% had history of vomiting, and all were children with an SW phenotype. Our cohort consisted of closely followed patients, with emphasis on adrenal crisis education and inperson demonstration of intramuscular dosing at each visit; as such, lack of glucocorticoid stress dosing education was not an issue. Based on our data presented in this study, we have revised our stress-dosing recommendations to include more frequent stress dosing at set intervals during childhood illnesses (every 6 hours) and frequent ingestion of simple and complex carbohydrates (Table 4) . Current stress-dose guidelines include high-dose glucocorticoid but not epinephrine, although it is known that epinephrine deficiency, present in patients with classic SW 21-hydroxylase deficiency (35) , predisposes to hypoglycemia. Although the need for glucocorticoid stress dosing for minor surgical procedures is questionable (36) , aggressive measures should be taken for infectious illnesses, especially in young patients with SW CAH. Finally, convenient, online, stress-dosing education is now widely available and may be of great use as a refresher for patients with adrenal insufficiency.
The strengths of our study include the prospective systematic data collection, the inclusion of both children and adults, the intensive education provided at each visit, and the evaluation of genetic and hormonal data, including epinephrine, in relation to illness episodes. Limitations include recall bias and subjective reporting of crises and events at patient visits, and the hormonal evaluation was obtained at follow-up visits, which may not reflect hormonal milieu around the time of the events. The symptoms of gastrointestinal illness closely mimic the presentation of adrenal crisis; therefore, it was not possible to distinguish the former as being a cause or a consequence of adrenal crisis. This may have led to overrepresentation of gastrointestinal illnesses as the most common etiology of adrenal crisis. The lack of a universal definition of adrenal crisis and the difficulty in detecting and documenting hypotension also contributed to our study limitations.
Patients with CAH are at risk for developing adrenal crisis, despite receiving comprehensive preventative education and guidelines aimed at optimizing home management. Rates of illnesses, the need to stress dose, and risk factors for ER visits and hospitalizations change throughout the life cycle. Although consideration of future studies of potential epinephrine administration in patients with adrenal crises may in theory be helpful to avert hypoglycemia, such trials may not be not feasible, especially in young children. Revised guidelines for the management of infectious illnesses in patients with adrenal insufficiency are needed and should include frequent glucocorticoid dosing in addition to guidance regarding carbohydrate and fluid intake aimed at prevention of hypoglycemia, especially during early childhood. Two to three times the usual dose of glucocorticoids, divided into four doses (to be given every 6 h) Take hydrocortisone 10 mg three times a day in addition to usual glucocorticoid regimen.
Major illness or high-grade fever (.39°C children)
Triple the usual dose of glucocorticoids and divide into four doses (i.e., take every 6 h). In addition, increased fluid intake and frequent ingestion of simple and complex carbohydrates Take hydrocortisone 20 mg three times a day in addition to usual glucocorticoid regimen; increased fluid intake with frequent ingestion of simple and complex carbohydrates Author Contributions: D.E.-M. wrote the initial draft of the manuscript, assisted in table and figure preparations, and supervised database extraction and preparation. C.J.H. was involved in preparation and extraction of data from electronic and paper medical records and drafted first versions of tables and figures. N.S. performed the statistical analysis for this work. A.M. and P.V. assisted in reviewing this work and were involved in the clinical management and stress-dose teaching of the patients. D.P.M. is the principal investigator for the CAH Natural History Study at the National Institutes of Health and supervised the entire work.
